# Study Evaluating Prevenar Vaccine in Healthy Infants

> **NCT00276107** · PHASE4 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 200 (—)

## Conditions studied

- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** Prevenar

## Key facts

- **NCT ID:** NCT00276107
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 200 (—)
- **Last updated:** 2009-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276107, "Study Evaluating Prevenar Vaccine in Healthy Infants". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00276107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*